Elke Faatz
29Patents
6h-index
41Co-inventors
69Inventor score
Filing activity: Jun 13, 1996 → Mar 28, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6645732B2 | Antigen-specific IgG detection | Emerging Cross-Sectional Technologies | 26 | Expired |
| US6489129B1 | Antigen-specific IgM detection | Emerging Cross-Sectional Technologies | 24 | Expired |
| US6613530B1 | Determination of a specific immunoglobulin using multiple antigens | Emerging Cross-Sectional Technologies | 21 | Expired |
| US7094884B2 | Soluble complexes of amylod β peptide and peptidyl prolyl isomerase chaperone and methods of making and using them | Physics | 19 | Expired |
| US6593079B1 | Method for simultaneous detection of HIV antigens and HIV antibodies | Chemistry; Metallurgy | 13 | Expired |
| US5804371A | Hapten-labelled peptides | Emerging Cross-Sectional Technologies | 12 | Expired |
| US9261510B2 | Detection of primary infections with pathogens | Physics | 6 | Active |
| US6153393A | Elimination of interference in diagnostic methods by peptides comprising D-amino acids | Emerging Cross-Sectional Technologies | 5 | Expired |
| US10101349B2 | Analytical test management system and method | Emerging Cross-Sectional Technologies | 5 | Active |
| US7244819B2 | Fusion polypeptides, vaccines and compositions of FKBP chaperones and target polypeptides | Physics | 5 | Expired |
| US6962982B2 | Soluble complexes of target proteins and peptidyl prolyl isomerase chaperones and methods of making and using them | Physics | 2 | Expired |
| US7604935B2 | Soluble rubella E1 envelope protein variants | Emerging Cross-Sectional Technologies | 2 | Active |
| US11312750B2 | Soluble and immunoreactive Zika virus NS1 polypeptides comprising the wing domain | Emerging Cross-Sectional Technologies | 1 | Active |
| US7244575B2 | Soluble complex comprising a retroviral surface glycoprotein | Physics | 1 | Expired |
| US11319351B2 | Soluble and immunoreactive flaviviral NS1 polypeptides comprising the wing domain | Emerging Cross-Sectional Technologies | 1 | Active |
| US7094757B2 | Complexes comprising a prion protein and a peptidyl prolyl isomerase chaperone, and method for producing and using them | Physics | 1 | Expired |
| US8551696B2 | Rubella E1 envelope protein variants and their use in detection of anti-rubella antibodies | Emerging Cross-Sectional Technologies | 0 | Active |
| US8426167B2 | Methods for producing fusion polypeptides or enhancing expression of fusion polypeptides | Physics | 0 | Active |
| US8247206B2 | Fusion protein comprising an Escherichia coli chaperone protein and a human chaperone protein | Chemistry; Metallurgy | 0 | Active |
| US10466242B2 | Soluble and immunoreactive variants of HTLV capsid antigen p24 | Emerging Cross-Sectional Technologies | 0 | Active |
| US7947494B2 | Fusion protein comprising an E. coli chaperone protein and a human chaperone protein | Chemistry; Metallurgy | 0 | Active |
| US8790659B2 | SlpA as a tool for recombinant protein and enzyme technology | Emerging Cross-Sectional Technologies | 0 | Active |
| US12018053B2 | Method for detecting flavivirus-specific antibodies utilizing flaviviral NS1 polypeptides comprising the wing domain | Emerging Cross-Sectional Technologies | 0 | Active |
| US9316642B2 | Soluble immunoreactive treponema pallidum TpN47 antigens | Physics | 0 | Active |
| US9714949B2 | Vibrio cholerae lipoprotein 15 (Lp15) variants as anti-interference additive in TpN17-based immunoassays for detection of anti-Treponema antibodies | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.